Bacterial cell membrane phospholipids and lipopolysaccharide components (LPS/PL)

Bacterial cell membrane phospholipids and lipopolysaccharide (LPS) components are essential structural and functional elements of the bacterial cell envelope (Nature Reviews Microbiology, 2010). LPS, also known as endotoxin, is a major constituent of the outer membrane of Gram-negative bacteria and is critical for maintaining membrane integrity and protecting the cell from chemical attacks (Frontiers in Immunology, 2020). Phospholipids are fundamental building blocks of both Gram-positive and Gram-negative membranes, providing the matrix for membrane proteins and maintaining the electrochemical gradient (Journal of Biological Chemistry, 2017). These components serve as vital therapeutic targets for several classes of antibiotics, including polymyxins and lipopeptides (StatPearls, 2023). Polymyxins specifically bind to the Lipid A moiety of LPS and phospholipids, disrupting the outer membrane of Gram-negative pathogens (Clinical Microbiology Reviews, 2019). Conversely, drugs like daptomycin target phospholipids in Gram-positive bacteria, causing rapid depolarization and cell death (Antimicrobial Agents and Chemotherapy, 2014). Targeting these lipid components is a key strategy in treating multidrug-resistant infections, although it carries risks of toxicity and the emergence of specific resistance mechanisms (The Lancet Infectious Diseases, 2016). Additionally, LPS plays a central role in the pathogenesis of sepsis by triggering an overactive host immune response through Toll-like receptor 4 (TLR4) (Immunity, 2013).

Other names

LipopolysaccharideLPSEndotoxinBacterial membrane lipidsLipid APhosphatidylglycerolBacterial cell envelope

Antibiotics targeting these components typically act by binding to specific lipid moieties, such as the negatively charged Lipid A in lipopolysaccharides or phosphatidylglycerol in phospholipids, leading to membrane depolarization, pore formation, and physical disruption of the bacterial cell envelope (Nature Reviews Drug Discovery, 2013; StatPearls, 2023).